These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6863492)

  • 1. [Characterization of protective activity in human sera against infection with Klebsiella ozaenae].
    Iwami S
    Nihon Ika Daigaku Zasshi; 1983 Apr; 50(2):264-70. PubMed ID: 6863492
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity of intravenous immune globulins against Klebsiella.
    Cryz SJ; Cross AS; Fürer E; Chariatte N; Sadoff JC; Germanier R
    J Lab Clin Med; 1986 Sep; 108(3):182-9. PubMed ID: 3746094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in immunization against Klebsiella infections.
    Cryz SJ
    Eur J Clin Microbiol; 1983 Dec; 2(6):523-8. PubMed ID: 6365535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunochemical properties of oligosaccharide-protein conjugates with Klebsiella-K2-specificity. II. Protective capacity of the conjugates and anti-conjugate antibodies against infection with Klebsiella pneumoniae 01:K2 in mice.
    Geyer H; Schlecht S; Himmelspach K
    Med Microbiol Immunol; 1982; 171(3):135-43. PubMed ID: 6186899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoprophylaxis against klebsiella and pseudomonas aeruginosa infections. The Federal Hyperimmune Immunoglobulin Trial Study Group.
    Donta ST; Peduzzi P; Cross AS; Sadoff J; Haakenson C; Cryz SJ; Kauffman C; Bradley S; Gafford G; Elliston D; Beam TR; John JF; Ribner B; Cantey R; Welsh CH; Ellison RT; Young EJ; Hamill RJ; Leaf H; Schein RM; Mulligan M; Johnson C; Abrutyn E; Griffiss JM; Slagle D
    J Infect Dis; 1996 Sep; 174(3):537-43. PubMed ID: 8769611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local immunity to klebsiella pneumoniae in the lungs of mice.
    Cooper JM; Finlay-Jones JJ; Hill NL; Rowley D
    J Infect Dis; 1983 Feb; 147(2):312-7. PubMed ID: 6338131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Passive protective activities of normal human sera against infection with strain K-9 of Klebsiella pneumoniae].
    Takahashi M; Ichiman Y; Ohshima Y; Yoshida K
    Kansenshogaku Zasshi; 1984 Nov; 58(11):1194-8. PubMed ID: 6442331
    [No Abstract]   [Full Text] [Related]  

  • 8. [The intensity and dynamics of the development of immunity in the administration of experimental corpuscular ozena vaccines].
    Molochko VA; Krasil'nikov AP; Krylov IA; Lastochkina TM
    Zh Mikrobiol Epidemiol Immunobiol; 1988 May; (5):49-52. PubMed ID: 3414235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Klebsiella polysaccharide vaccines.
    Cryz SJ
    Adv Biotechnol Processes; 1990; 13():87-103. PubMed ID: 2185788
    [No Abstract]   [Full Text] [Related]  

  • 10. Production and characterization of a human hyperimmune intravenous immunoglobulin against Pseudomonas aeruginosa and Klebsiella species.
    Cryz SJ; Fürer E; Sadoff JC; Fredeking T; Que JU; Cross AS
    J Infect Dis; 1991 May; 163(5):1055-61. PubMed ID: 1902245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to Klebsiella pneumoniae and the importance of two bacterial antigens.
    Cooper JM; Rowley D
    Aust J Exp Biol Med Sci; 1982 Dec; 60(6):629-41. PubMed ID: 6820634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-B27, Klebsiella, and ankylosing spondylitis.
    Geczy AF; Yap J
    Lancet; 1979 Mar; 1(8118):719-20. PubMed ID: 85952
    [No Abstract]   [Full Text] [Related]  

  • 13. O antigen seroepidemiology of Klebsiella clinical isolates and implications for immunoprophylaxis of Klebsiella infections.
    Trautmann M; Held TK; Cross AS
    Vaccine; 2004 Feb; 22(7):818-21. PubMed ID: 15040933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Klebsiella pneumoniae type 3 fimbria-mediated immunity to infection in the murine model of respiratory disease.
    Lavender H; Jagnow JJ; Clegg S
    Int J Med Microbiol; 2005 Jun; 295(3):153-9. PubMed ID: 16047414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunobiological properties and therapeutic effectiveness of preparations from Klebsiella bacteriophages].
    Bogovazova GG; Voroshilova NN; Bondarenko VM; Gorbatkova GA; Afanas'eva EV; Kazakova TB; Smirnov VD; Mamleeva AG; Glukharev IuA; Erastova EI
    Zh Mikrobiol Epidemiol Immunobiol; 1992 Mar; (3):30-3. PubMed ID: 1380753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Passive immunisation against Gram-negative bacilli in burns.
    Jones RJ
    Br J Exp Pathol; 1970 Feb; 51(1):53-8. PubMed ID: 4985031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with R mutants of S. Minnesota. I. Protection against challenge with heterologous gram-negative bacilli.
    McCabe WR
    J Immunol; 1972 Mar; 108(3):601-10. PubMed ID: 4622185
    [No Abstract]   [Full Text] [Related]  

  • 18. Preliminary investigation of a mice model of Klebsiella pneumoniae subsp. ozaenae induced pneumonia.
    Renois F; Jacques J; Guillard T; Moret H; Pluot M; Andreoletti L; de Champs C
    Microbes Infect; 2011 Nov; 13(12-13):1045-51. PubMed ID: 21723409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of i.v. immunoglobulins on experimental infections--especially in combination with antibiotics].
    Sunakawa K; Akita H; Yamashita N; Jozaki K; Iwata S; Iwasaki Y; Sato Y; Tojo M; Osano M; Ichihashi Y
    Kansenshogaku Zasshi; 1982 Dec; 56(12):1196-202. PubMed ID: 6820034
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic and opsonizing effect of specific antibacterial immunoglobulins in experimental Klebsiella septicemia in mice].
    Trautmann M; Fischer GI; Hahn H
    Immun Infekt; 1984 Feb; 12(1):56-60. PubMed ID: 6398272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.